Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$170,391,231
+$46,305,574 QoQ
Shares Held
677,123
+18.7% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#179
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIL Ltd holds $2,310,187,043 across 11 Drug Manufacturers - General names. ABBV ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,492,612 | $851,889,084 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,523,813 | $375,902,104 | |
| 3 | PFE |
Pfizer Inc
|
10,482,713 | $252,423,729 | |
| 4 | LLY |
ELI LILLY & Co
|
201,889 | $242,151,742 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
677,123 | $170,391,231 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
987,104 | $124,710,718 | |
| 7 | JNJ |
Johnson & Johnson
|
431,712 | $109,641,896 | |
| 8 | MRK |
Merck & Co., Inc.
|
678,957 | $87,245,974 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $170,391,231 | 677,123 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $124,085,657 | 570,535 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $131,499,193 | 575,514 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $125,095,968 | 540,278 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $77,201,771 | 415,913 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $65,501,818 | 312,628 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $43,522,994 | 244,924 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $111,638,208 | 565,314 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $86,353,802 | 503,462 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $68,950,344 | 378,640 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $54,147,602 | 349,407 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $84,878,937 | 569,428 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $101,668,335 | 754,608 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $118,298,438 | 742,288 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $122,533,025 | 758,202 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $105,209,097 | 783,914 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $123,830,166 | 808,502 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $105,985,572 | 653,788 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $68,347,889 | 504,785 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $52,473,685 | 486,453 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $56,989,869 | 505,947 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $42,997,860 | 397,319 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $42,761,635 | 399,082 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | $136,515,933 | 1,558,579 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $147,667,921 | 1,504,053 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $88,159,753 | 1,157,104 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||